Back to top
more

Nivalis Therapeutics, Inc. (ALPN)

(Delayed Data from NSDQ)

$6.24 USD

6.24
7,474

-0.08 (-1.27%)

Updated May 3, 2019 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

2 items in cart

View Cart/Checkout

[ALPN]

Reports for Purchase

Showing records 121 - 140 ( 156 total )

Industry: Medical - Drugs

Record: 121

06/22/2020

Daily Note

Pages: 6

Preclinical AACR II Update: ALPN-202 MOA Extends to Macrophages

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 122

06/19/2020

Daily Note

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 123

06/19/2020

Company Report

Pages: 9

AbbVie Partnership Directs ALPN-101 to Lupus; Raising PT to $22

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 124

06/08/2020

Company Report

Pages: 8

EULAR 2020 Takeaways: ALPN-101 HV Update and New B Cell Preclinical Programs

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 125

05/15/2020

Company Report

Pages: 7

Q1 Financials; First Patient Dosed in BALANCE Acute GvHD Study

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 126

04/29/2020

Industry Report

Pages: 19

Takeaways from First AACR Virtual Meeting

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 127

04/14/2020

Daily Note

Pages: 9

CORRECTED AACR 2020 Titles for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 128

03/31/2020

Company Report

Pages: 6

Q4 Financials; BALANCE and NEON-1 Studies Now Open for Enrollment

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 129

03/28/2020

Industry Report

Pages: 12

HEALTHCARE - The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 130

12/09/2019

Daily Note

Pages: 6

ALPN-101 Healthy Volunteer Safety Looks Clean; BALANCE Study Details Announced

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 131

12/02/2019

Industry Report

Pages: 16

The Monthly Check-Up

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 132

11/19/2019

Daily Note

Pages: 6

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 133

11/18/2019

Company Report

Pages: 7

Q3 Financials; ALPN-101 Data Presentation at ASH Ahead

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 134

11/15/2019

Daily Note

Pages: 35

2019 Abstract Roundup for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 135

11/08/2019

Industry Report

Pages: 9

HEALTHCARE - The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 136

11/01/2019

Daily Note

Pages: 13

Biotechnology - SITC 2019 Abstract Title Preview for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 137

08/19/2019

Company Report

Pages: 7

Q2 Financials; IND for ALPN-202 on Track for 2H:19

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 138

08/19/2019

Daily Note

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 139

08/14/2019

Industry Report

Pages: 20

2019 PacGrow Healthcare Conference: Day 1 Recap

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 140

05/16/2019

Daily Note

Pages: 4

Adaptimmune taps Alpine Immune for 2nd Gen. TCR Therapies

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 10.00

Research Provided by a Third Party